Isam Alobid

Grup de recerca

Immunoal·lèrgia respiratòria clínica i experimental (IRCE) Accredited researcher (R3A)

ialobid@clinic.cat 0000-0001-7204-5599

Segueix-lo/a a:

El perfil de ResearchGate de Isam . Aquest enllaç s'obre en una nova pestanya.

Publicacions destacades

Paediatric Barcelona Olfactory Test-6 (pBOT-6): Validation of a Combined Odour Identification and Threshold Screening Test in Healthy Spanish Children and Adolescents

Autors:
Marino-Sanchez, F; Valls-Mateus, M; Fragola, C; de los Santos, G; Aguirre, A;

(...)

Santamaria, A; Rojas Lechuga, M J; Cobeta, I; Alobid, I; Mullol, J.

Referència: Journal Of Investigational Allergology And Clinical Immunology 2020.
Olfactory Training Prevents Olfactory Dysfunction Induced by Bulbar Excitotoxic Lesions: Role of Neurogenesis and Dopaminergic Interneurons

Autors:
Marin, Concepcio; Laxe, Sara; Langdon, Cristobal; Alobid, Isam; Berenguer, Joan;

Fuentes, Mireya; Bernabeu, Montserrat; Mullol, Joaquim.

Referència: Molecular Neurobiology 2019.
Recovery of Olfactory Function After Excitotoxic Lesion of the Olfactory Bulbs Is Associated with Increases in Bulbar SIRT1 and SIRT4 Expressions

Autors:
Marin, Concepcio; Langdon, Cristobal; Alobid, Isam; Fuentes, Mireya; Bonastre, Merce;

Mullol, Joaquim.

Referència: Molecular Neurobiology 2019.
European position paper on diagnostic tools in rhinology

Autors:
Rimmer, Joanne; Hellings, Peter; Lund, Valerie J; Alobid, Isam; Beale, Timothy;

(...)

Psaltis, Alkis; Surda, Pavol; Tomazic, Peter Valentin; Vent, Julia; Fokkens, Wytske.

Referència: Rhinology 2019.
Patient Advisory Board for Chronic Rhinosinusitis - A EUFOREA initiative

Autors:
Pugin, B; Deneyer, L; Bachert, C; Alobid, I; Bousquet, J;

(...)

Pereira-Perez, C; Tomazic, P, V; Vanderveken, O; Hellings, P W; Seys, S F.

Referència: Rhinology 2019.
The GALEN rhinosinusitis cohort: chronic rhinosinusitis with nasal polyps affects health-related quality of life

Autors:
Khan, Asif; Thi Minh Thao Huynh; Vandeplas, Griet; Joish, Vijay N; Mannent, Leda P;

(...)

Hox, Valerie; Toskala, Elina; Scadding, Glenis; Lund, Valerie; Bachert, Claus.

Referència: Rhinology 2019.
Self-perception of olfactory dysfunction is associated with history of Traumatic Brain Injury: post-hoc analysis from the OLFACAT survey

Autors:
Langdon, Cristobal; Alobid, Isam; Quinto, Llorenc; Valero, Antonio; Picado, Cesar;

Marin, Concepcio; Mullol, Joaquim.

Referència: Rhinology 2019.
Modified nasal floor and inferior meatus flap for septal perforation repair. Extension and limits.

Autors:
Santamaria-Gadea A; et al; Alobid I;

Referència: Rhinology. 2018.
Olfactory Dysfunction in Neurodegenerative Diseases

Autors:
Marin C; Vilas D; Langdon C; Alobid I; López-Chacón M;

Haehner A; Hummel T; Mullol J.

Referència: Current Allergy And Asthma Reports 2018.

Projectes destacats

Expression of Rupatadine on PAF-induced inflammation in blood eosinophils and epithelial cells from nasal polyps and healthy nasal mucosa (RINOPAF-2 Study).

Investigador/a principal: Joaquim Mullol I Miret

Finançador: URIACH S.A

Codi: RINOPAF-02-2018

Durada: 01/01/2019 - 31/12/2021
El impacto de la inflamación sobre el sentido del olfato en pacientes con poliposis nasal: El rol de los eosinófilos sobre la neurogenesis del neuroepitelio olfatorio.

Investigador/a principal: Isam Alobid

Finançador: Fundació Privada Clínic per a la Recerca Biomèdica (Sede o evento); Fondo Investigaciones Sanitarias (FIS)

Codi: (PI15/00262)

Durada: 01/01/2016 - 31/12/2019
Study of the antiinflammatory mechanisms of action of MP29-02, compared to fluticasone propionate and azelastine alone, in healthy and inflamed human ansal mucosa: regulation on anti- and pro-inflammatory genes and GR.

Investigador/a principal: Joaquim Mullol I Miret

Finançador: MEDA Pharma

Codi: DYMECOS II

Durada: 01/01/2016 - 31/12/2019
Randomized double-blind, phase III, placebo controlled, to evaluate dupilumab in patients with bilateral nasal polyposis and symptoms of chronic sinusitis.

Finançador: Sanofi Aventis, S.A. ; CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER (Participante)

Durada: 01/01/2016
Randomized double-blind, phase II, placebo controlled, 2 arm study to evaluate dupilumab in patients with bilateral nasal polyposis and symptoms of chronic sinusitis.

Finançador: Sanofi Aventis, S.A. ; CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER (Participante)

Durada: 01/01/2014

Isam Alobid

Grup de recerca

Publicacions destacades

Projectes destacats

Expression of Rupatadine on PAF-induced inflammation in blood eosinophils and epithelial cells from nasal polyps and healthy nasal mucosa (RINOPAF-2 Study).

El impacto de la inflamación sobre el sentido del olfato en pacientes con poliposis nasal: El rol de los eosinófilos sobre la neurogenesis del neuroepitelio olfatorio.

Study of the antiinflammatory mechanisms of action of MP29-02, compared to fluticasone propionate and azelastine alone, in healthy and inflamed human ansal mucosa: regulation on anti- and pro-inflammatory genes and GR.

Randomized double-blind, phase III, placebo controlled, to evaluate dupilumab in patients with bilateral nasal polyposis and symptoms of chronic sinusitis.

Randomized double-blind, phase II, placebo controlled, 2 arm study to evaluate dupilumab in patients with bilateral nasal polyposis and symptoms of chronic sinusitis.

Subscriu-te a la Newsletter del Clínic